CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2020; 11(01): 89-91
DOI: 10.1055/s-0040-1712335
Review Article

Way Forward: Gastrointestinal Tract Endoscopy Work Flow Postlockdown Era

Randhir Sud
1   Institute of Digestive and Hepato-biliary Sciences, Medanta the Medicity, Gurgaon, Haryana, India
,
Sukrit Sud
1   Institute of Digestive and Hepato-biliary Sciences, Medanta the Medicity, Gurgaon, Haryana, India
› Institutsangaben

Abstract

Gastrointestinal tract endoscopy being an aerosol generating procedure increases the risk to staff and uninfected patients from a coronavirus disease 2019 patient. Social and physical distancing through “lockdown” has suppressed the spread of disease but will not eradicate it. Various endoscopy societies formulated guidelines to triage the patients and limit the work to only emergency and urgent cases and postpone “routine” endoscopies. Postlockdown infected vector pool will persist till an effective vaccine is widely available. Nonurgent cases cannot be postponed indefinitely. We need to identify infected symptomatic and asymptomatic individuals and create a safe environment for uninfected patients. Endoscopy staff protection through education, optimized manpower flow, and personal protective equipment usage and hand hygiene needs urgent attention. Proper environment sanitization, endoscope, and device reprocessing will remain important.



Publikationsverlauf

Artikel online veröffentlicht:
16. Mai 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395 (10223) 470-473
  • 2 Chen L, Lou J, Bai Y, Wang M. COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests. Am J Gastroenterol 2020
  • 3 Remuzzi A, Remuzzi G. COVID-19 and Italy: what next?. Lancet 2020; 395 (10231) 1225-1228
  • 4 Characteristics of Health Care Personnel with COVID-19—United States. CDC Weekly Morbid Mortal Rep 2020 Available at: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e6.html Accessed April 29, 2020
  • 5 Chiu PWY, Ng SC, Inoue H. et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut 2020; gutjnl-2020-321185
  • 6 Mathew P, Lakhtakia S, Agarwal R, et al. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care and Management of patients with COVID-19. J Clin Experiment Hepatol 2020; doi.org/10.1016/j.jceh.2020.04.001
  • 7 Chan JF, Yuan S, Kok KH. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395 (10223) 514-523
  • 8 Ong J, Cross GB, Dan YY The prevention of nosocomial SARS-CoV2 transmission in endoscopy: a systematic review of recommendations within gastroenterology to identify best practice.Medrxiv2020 Available at https://www.medrxiv.org/content/10.1101/2020.03.17.20037564v1 Accessed April 29, 2020
  • 9 Lou B, Li T, Zheng S, Su Y, Li Z. Serology characteristics of SARSCoV- 2 infection since the exposure and post symptoms onset. Norwegian Inst Publ Healt. 2020
  • 10 Calderwood AH, Day LW, Muthusamy VR. et al. ASGE Quality Assurance in Endoscopy Committee. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc 2018; 87 (05) 1167-1179
  • 11 Sultan S, Lim JK, Altayar O. et al. AGA. AGA Institute Rapid Recommendations for gastrointestinal procedures during the COVID-19 pandemic. Gastroenterology 2020; S0016-5085 (20) 30458-3
  • 12 Repici A, Maselli R, Colombo M. et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 2020; S0016-5107 (20) 30245-5
  • 13 Vavricka SR, Tutuian R, Imhof A. et al. Air suctioning during colon biopsy forceps removal reduces bacterial air contamination in the endoscopy suite. Endoscopy 2010; 42 (09) 736-741
  • 14 Zhongji M, Tongyu W, Li C. An experimental trial of recombinant human interferon alpha nasal drops to prevent coron:avirus disease 2019 in medical staff in an epidemic areaMedRxiv2020 Available at https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v1 Accessed April 29, 2020